Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure (Q74315515)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

main subject

chronic heart failure

1 reference

S D Katz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

K Balidemaj

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S Homma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H Wu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Wang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S Maybaum

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

845-851

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

Regulatory functions of the vascular endothelium

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Endothelium-dependent vasodilation is attenuated in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Endothelium-dependent vasodilatation is not selectively impaired in patients with chronic heart failure secondary to valvular heart disease and congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Cyclic GMP and mechanisms of vasodilation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Sildenafil, a novel effective oral therapy for male erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Effects of sildenafil citrate on human hemodynamics.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Limb vascular responsiveness to beta-adrenergic receptor stimulation in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Relation between impairment in nitric oxide pathway and clinical status in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

Overall cardiovascular profile of sildenafil citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900790-7

7 January 2021

10.1016/S0735-1097(00)00790-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10987609%20AND%20SRC:MED&resulttype=core&format=json